|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
123,030,000 |
Market
Cap: |
18.60(B) |
Last
Volume: |
934,860 |
Avg
Vol: |
724,527 |
52
Week Range: |
$143.31 - $211.65 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 824 |
Guru Rank Value : 0.5 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
45,264 |
76,855 |
102,504 |
247,093 |
Total Sell Value |
$6,835,665 |
$12,957,715 |
$17,713,340 |
$48,829,179 |
Total People Sold |
6 |
7 |
8 |
9 |
Total Sell Transactions |
10 |
12 |
18 |
35 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Keating Laurie |
SVP, GC & Secretary |
|
2018-03-13 |
4 |
AS |
$150.00 |
$1,500,000 |
D/D |
(10,000) |
14,500 |
|
- |
|
Keating Laurie |
SVP, GC & Secretary |
|
2018-03-13 |
4 |
OE |
$77.40 |
$774,000 |
D/D |
10,000 |
24,500 |
|
- |
|
Keating Laurie |
SVP, GC & Secretary |
|
2018-03-12 |
4 |
AS |
$140.00 |
$1,400,000 |
D/D |
(10,000) |
14,500 |
|
- |
|
Keating Laurie |
SVP, GC & Secretary |
|
2018-03-12 |
4 |
OE |
$77.40 |
$774,000 |
D/D |
10,000 |
24,500 |
|
- |
|
Sharp Philip A |
Director |
|
2018-03-09 |
4 |
AS |
$129.00 |
$1,935,000 |
D/D |
(15,000) |
140,795 |
|
- |
|
Sharp Philip A |
Director |
|
2018-03-09 |
4 |
OE |
$27.28 |
$409,200 |
D/D |
15,000 |
155,795 |
|
- |
|
Greene Barry E |
President |
|
2018-01-17 |
4 |
A |
$0.00 |
$0 |
I/I |
17 |
2,827 |
|
- |
|
Soni Manmeet Singh |
Chief Financial Officer |
|
2018-01-17 |
4 |
A |
$0.00 |
$0 |
I/I |
6 |
19 |
|
- |
|
Mason Michael |
VP, Finance and Treasurer |
|
2018-01-17 |
4 |
A |
$0.00 |
$0 |
I/I |
5 |
231 |
|
- |
|
Mason Michael |
VP, Finance and Treasurer |
|
2018-01-04 |
4 |
AS |
$130.42 |
$4,835,171 |
D/D |
(36,745) |
0 |
|
- |
|
Mason Michael |
VP, Finance and Treasurer |
|
2018-01-04 |
4 |
OE |
$42.22 |
$2,804,911 |
D/D |
31,781 |
36,745 |
|
- |
|
Mason Michael |
VP, Finance and Treasurer |
|
2017-12-30 |
4 |
D |
$127.05 |
$449,503 |
D/D |
(3,538) |
4,964 |
|
- |
|
Mason Michael |
VP, Finance and Treasurer |
|
2017-12-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,502 |
8,502 |
|
- |
|
Keating Laurie |
SVP, GC & Secretary |
|
2017-12-29 |
4 |
OE |
$77.40 |
$232,200 |
D/D |
3,000 |
14,500 |
|
- |
|
Keating Laurie |
SVP, GC & Secretary |
|
2017-12-20 |
4 |
AS |
$120.88 |
$757,398 |
D/D |
(6,249) |
11,500 |
|
- |
|
Keating Laurie |
SVP, GC & Secretary |
|
2017-12-20 |
4 |
OE |
$42.22 |
$263,833 |
D/D |
6,249 |
17,749 |
|
- |
|
Vaishnaw Akshay |
EVP, R&D |
|
2017-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
320 |
11,215 |
|
- |
|
Maraganore John |
Chief Executive Officer |
|
2017-12-19 |
4 |
OE |
$63.00 |
$99,981 |
D/D |
1,587 |
151,297 |
|
- |
|
Keating Laurie |
SVP, GC and Secretary |
|
2017-12-01 |
4 |
AS |
$133.37 |
$4,076,823 |
D/D |
(30,000) |
11,500 |
|
- |
|
Keating Laurie |
SVP, GC and Secretary |
|
2017-12-01 |
4 |
OE |
$77.40 |
$2,322,000 |
D/D |
30,000 |
41,500 |
|
- |
|
Maraganore John |
Chief Executive Officer |
|
2017-11-22 |
4 |
AS |
$129.97 |
$9,609,736 |
D/D |
(73,415) |
149,710 |
|
- |
|
Maraganore John |
Chief Executive Officer |
|
2017-11-22 |
4 |
OE |
$31.39 |
$2,304,497 |
D/D |
73,415 |
223,125 |
|
- |
|
Maraganore John |
Chief Executive Officer |
|
2017-11-15 |
4 |
AS |
$125.54 |
$9,387,951 |
D/D |
(74,000) |
149,710 |
|
- |
|
Maraganore John |
Chief Executive Officer |
|
2017-11-15 |
4 |
OE |
$31.39 |
$2,322,860 |
D/D |
74,000 |
223,710 |
|
- |
|
Ausiello Dennis A |
Director |
|
2017-11-02 |
4 |
AS |
$130.00 |
$2,600,000 |
D/D |
(20,000) |
0 |
|
- |
|
746 Records found
|
|
Page 13 of 30 |
|
|